share_log

Keybanc Maintains Overweight on Health Catalyst, Lowers Price Target to $10

Benzinga ·  Feb 26 05:19

Keybanc analyst Scott Schoenhaus maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target from $12 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment